Molecular Genetic Delineation of 2Q37.3 Deletion in Autism and Osteodystrophy: Report of a Case and of New Markers for Deletion Screening by PCR
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis. -
Downloaded from the National Database for Autism Research (NDAR)
International Journal of Molecular Sciences Article Phenotypic Subtyping and Re-Analysis of Existing Methylation Data from Autistic Probands in Simplex Families Reveal ASD Subtype-Associated Differentially Methylated Genes and Biological Functions Elizabeth C. Lee y and Valerie W. Hu * Department of Biochemistry and Molecular Medicine, The George Washington University, School of Medicine and Health Sciences, Washington, DC 20037, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-202-994-8431 Current address: W. Harry Feinstone Department of Molecular Microbiology and Immunology, y Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Received: 25 August 2020; Accepted: 17 September 2020; Published: 19 September 2020 Abstract: Autism spectrum disorder (ASD) describes a group of neurodevelopmental disorders with core deficits in social communication and manifestation of restricted, repetitive, and stereotyped behaviors. Despite the core symptomatology, ASD is extremely heterogeneous with respect to the severity of symptoms and behaviors. This heterogeneity presents an inherent challenge to all large-scale genome-wide omics analyses. In the present study, we address this heterogeneity by stratifying ASD probands from simplex families according to the severity of behavioral scores on the Autism Diagnostic Interview-Revised diagnostic instrument, followed by re-analysis of existing DNA methylation data from individuals in three ASD subphenotypes in comparison to that of their respective unaffected siblings. We demonstrate that subphenotyping of cases enables the identification of over 1.6 times the number of statistically significant differentially methylated regions (DMR) and DMR-associated genes (DAGs) between cases and controls, compared to that identified when all cases are combined. Our analyses also reveal ASD-related neurological functions and comorbidities that are enriched among DAGs in each phenotypic subgroup but not in the combined case group. -
The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease
International Journal of Molecular Sciences Review The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease Chunling Huang * , Ji Bian , Qinghua Cao, Xin-Ming Chen and Carol A. Pollock * Kolling Institute, Sydney Medical School, Royal North Shore Hospital, University of Sydney, St. Leonards, NSW 2065, Australia; [email protected] (J.B.); [email protected] (Q.C.); [email protected] (X.-M.C.) * Correspondence: [email protected] (C.H.); [email protected] (C.A.P.); Tel.: +61-2-9926-4784 (C.H.); +61-2-9926-4652 (C.A.P.) Abstract: Mitochondria are critical organelles that play a key role in cellular metabolism, survival, and homeostasis. Mitochondrial dysfunction has been implicated in the pathogenesis of diabetic kidney disease. The function of mitochondria is critically regulated by several mitochondrial protein kinases, including the phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1). The focus of PINK1 research has been centered on neuronal diseases. Recent studies have revealed a close link between PINK1 and many other diseases including kidney diseases. This review will provide a concise summary of PINK1 and its regulation of mitochondrial function in health and disease. The physiological role of PINK1 in the major cells involved in diabetic kidney disease including proximal tubular cells and podocytes will also be summarized. Collectively, these studies suggested that targeting PINK1 may offer a promising alternative for the treatment of diabetic kidney disease. Keywords: PINK1; diabetic kidney disease; mitochondria; mitochondria quality control; mitophagy Citation: Huang, C.; Bian, J.; Cao, Q.; 1. Introduction Chen, X.-M.; Pollock, C.A. -
A Network of Bhlhzip Transcription Factors in Melanoma: Interactions of MITF, TFEB and TFE3
A network of bHLHZip transcription factors in melanoma: Interactions of MITF, TFEB and TFE3 Josué A. Ballesteros Álvarez Thesis for the degree of Philosophiae Doctor January 2019 Net bHLHZip umritunarþátta í sortuæxlum: Samstarf milli MITF, TFEB og TFE3 Josué A. Ballesteros Álvarez Ritgerð til doktorsgráðu Leiðbeinandi/leiðbeinendur: Eiríkur Steingrímsson Doktorsnefnd: Margrét H. Ögmundsdóttir Þórarinn Guðjónsson Jórunn E. Eyfjörð Lars Rönnstrand Janúar 2019 Thesis for a doctoral degree at tHe University of Iceland. All rigHts reserved. No Part of tHis Publication may be reProduced in any form witHout tHe Prior permission of the copyright holder. © Josue A. Ballesteros Álvarez. 2019 ISBN 978-9935-9421-4-2 Printing by HáskólaPrent Reykjavik, Iceland 2019 Ágrip StjórnPróteinin MITF , TFEB, TFE3 og TFEC (stundum nefnd MiT-TFE þættirnir) tilheyra bHLHZip fjölskyldu umritunarþátta sem bindast DNA og stjórna tjáningu gena. MITF er mikilvægt fyrir myndun og starfsemi litfruma en ættingjar þess, TFEB og TFE3, stjórna myndun og starfsemi lysósóma og sjálfsáti. Sjálfsát er líffræðilegt ferli sem gegnir mikilvægu hlutverki í starfsemi fruma en getur einnig haft áHrif á myndun og meðHöndlun sjúkdóma. Í verkefni þessu var samstarf MITF, TFE3 og TFEB Próteinanna skoðað í sortuæxlisfrumum og hvaða áhrif þau Hafa á tjáningu hvers annars. Eins og MITF eru TFEB og TFE3 genin tjáð í sortuæxlisfrumum og sortuæxlum; TFEC er ekki tjáð í þessum frumum og var því ekki skoðað í þessu verkefni. Með notkun sérvirkra hindra var sýnt að boðleiðir hafa áhrif á staðsetningu próteinanna þriggja í sortuæxlisfrumum. Umritunarþættir þessir geta bundist skyldum DNA-bindisetum og haft áhrif á tjáningu gena sem eru nauðsynleg fyrir myndun bæði lýsósóma og melanósóma. -
Identification of Phosphoproteins Involved in Sperm
IDENTIFICATION OF PHOSPHOPROTEINS INVOLVED IN SPERM MATURATION AND FERTILITY. A dissertation submitted to Kent State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy by Suranjana Goswami August 2018 © Copyright All rights reserved Except for previously published materials Dissertation written by Suranjana Goswami B.Sc., University of Calcutta, India, 2009 M.Sc., University of Calcutta, India 2011 Ph.D., Kent State University, USA, 2018 Approved by Dr. Srinivasan Vijayaraghavan , Chair, Doctoral Dissertation Committee Dr. Douglas W. Kline , Members, Doctoral Dissertation Committee Dr. Gary Koshi , Dr. Sanjaya Abeysirigunawardena , Dr. Andrew Jasnow , Accepted by Dr. Laura G. Leff , Chair, Department of Biological Sciences Dr. James L. Blank , Dean, College of Arts and Sciences TABLE OF CONTENTS ............................................................................................................... iii LIST OF FIGURES ..........................................................................................................................v LIST OF TABLES ....................................................................................................................... viii ABBREVIATIONS ....................................................................................................................... ix DEDICATION ............................................................................................................................... xi ACKNOWLEDGEMENTS ......................................................................................................... -
Role of Glypican-6 and Ng2 As Metastasis Promoting Factors
UNIVERSITA’ DEGLI STUDI DI PARMA Dottorato di ricerca in Fisiopatologia Sistemica Ciclo XX ROLE OF GLYPICAN-6 AND NG2 AS METASTASIS PROMOTING FACTORS Coordinatore: Chiar.mo Prof. Ezio Musso Tutor: Chiar.mo Prof.Roberto Perris Dottoranda: Katia Lacrima Anni Accademici 2005-2008 To Indy L'anima libera e' rara, ma quando la vedi la riconosci: soprattutto perché provi un senso di benessere, quando gli sei vicino. (Charles Bukowski ) Index Summary ……………………………………………………..................................................... 3 1. Introduction …………………………………………………………………………………… 5 1.1. Proteoglycans (PGs)………………………………………………………………......... 6 1.2. Membrane associated proteoglycans……………………………………………..…... 8 1.3. Syndecans……………………………………………………………………………..…. 9 1.4. Glypicans……………………………………………………………………………...….. 11 1.5. GPC6……………………………………………………………………………….…….. 13 1.6. NG2/CSPG4……………………………………………………………………….…….. 14 1.7. Metastasis………………………………………………………………………….….…. 16 1.8. Soft Tissue Sarcoma (STS)…………………………………………………………….. 17 1.9. Membrane PGs and tumour……………………………………………………………. 18 1.10. Membrane PGs in sarcoma…………………………………………………………….. 24 2. Material and Methods ……………………………………………………………………… 26 2.1. Cell Culture……………………………………………………………………….………. 27 2.2. RNA extraction……………………………………………………………………….…. 28 2.3. Real Time quantitative PCR……………………………………………….………….. 28 2.4. DNA extraction…………………………………………….……………………………. 30 2.5. Plasmids and Transfection………………………………………….………………… 30 2.6. Western Blotting………………………………………………………………………... 31 2.7. Preparation of ECM substrates………………………………………….…………… -
The Lavender Plumage Colour in Japanese Quail Is
Bed’hom et al. BMC Genomics 2012, 13:442 http://www.biomedcentral.com/1471-2164/13/442 RESEARCH ARTICLE Open Access The lavender plumage colour in Japanese quail is associated with a complex mutation in the region of MLPH that is related to differences in growth, feed consumption and body temperature Bertrand Bed’hom1, Mohsen Vaez2,5, Jean-Luc Coville1, David Gourichon3, Olivier Chastel4, Sarah Follett2, Terry Burke2 and Francis Minvielle1,6* Abstract Background: The lavender phenotype in quail is a dilution of both eumelanin and phaeomelanin in feathers that produces a blue-grey colour on a wild-type feather pattern background. It has been previously demonstrated by intergeneric hybridization that the lavender mutation in quail is homologous to the same phenotype in chicken, which is caused by a single base-pair change in exon 1 of MLPH. Results: In this study, we have shown that a mutation of MLPH is also associated with feather colour dilution in quail, but that the mutational event is extremely different. In this species, the lavender phenotype is associated with a non-lethal complex mutation involving three consecutive overlapping chromosomal changes (two inversions and one deletion) that have consequences on the genomic organization of four genes (MLPH and the neighbouring PRLH, RAB17 and LRRFIP1). The deletion of PRLH has no effect on the level of circulating prolactin. Lavender birds have lighter body weight, lower body temperature and increased feed consumption and residual feed intake than wild-type plumage quail, indicating that this complex mutation is affecting the metabolism and the regulation of homeothermy. Conclusions: An extensive overlapping chromosome rearrangement was associated with a non-pathological Mendelian trait and minor, non deleterious effects in the lavender Japanese quail which is a natural knockout for PRLH. -
1 Genetic Determinants of Interventricular Septal Anatomy and the Risk of Ventricular Septal
medRxiv preprint doi: https://doi.org/10.1101/2021.04.19.21255650; this version posted April 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . 1 Genetic determinants of interventricular septal anatomy and the risk of ventricular septal 2 defects and hypertrophic cardiomyopathy. 3 4 Mengyao Yu PhD1,2*, Andrew R. Harper MRCP DPhil3,4,5*, Matthew Aguirre AB1,6, Maureen 5 Pittman 7,8, Catherine Tcheandjieu DVM PhD1,2,9, Dulguun Amgalan PhD10,11, Christopher 6 Grace PhD3,4, Anuj Goel MBBS MSc3,4, Martin Farrall FRCPath3,4, Ke Xiao MS12, Jesse 7 Engreitz PhD10,11, Katherine Pollard PhD7,8,13, Hugh Watkins MD PhD3,4, James R. Priest 8 MD1,2,13,14 9 10 Affiliations: 11 1) Department of Pediatrics, Division of Pediatric Cardiology, Stanford University School 12 of Medicine, Stanford, California, USA 13 2) Stanford Cardiovascular Institute, Stanford University, Stanford, California, USA 14 3) Radcliffe Department of Medicine, University of Oxford, Division of Cardiovascular 15 Medicine, John Radcliffe Hospital, Oxford, UK. 16 4) Wellcome Centre for Human Genetics, Roosevelt Drive, Oxford, UK. 17 5) Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, 18 AstraZeneca, Cambridge, UK 19 6) Department of Biomedical Data Science, Stanford Medical School 20 7) University of California, San Francisco, San Francisco, CA, USA 21 8) Gladstone -
Prognostic Value of Glypican Family Genes in Early-Stage Pancreatic Ductal Adenocarcinoma After Pancreaticoduodenectomy and Possible Mechanisms
Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms Jun-qi Liu Guangxi Medical University First Aliated Hospital Xi-wen Liao Guangxi Medical University First Aliated Hospital Xiang-kun Wang Guangxi Medical University First Aliated Hospital Cheng-kun Yang Guangxi Medical University First Aliated Hospital Xin Zhou Guangxi Medical University First Aliated Hospital Zheng-qian Liu Guangxi Medical University First Aliated Hospital Quan-fa Han Guangxi Medical University First Aliated Hospital Tian-hao Fu Guangxi Medical University First Aliated Hospital Guang-zhi Zhu Guangxi Medical University First Aliated Hospital Chuang-ye Han Guangxi Medical University First Aliated Hospital Hao Su Guangxi Medical University First Aliated Hospital Jian-lu Huang Guangxi Medical University First Aliated Hospital Guo-tian Ruan Guangxi Medical University First Aliated Hospital Ling Yan Guangxi Medical University First Aliated Hospital Xin-ping Ye Guangxi Medical University First Aliated Hospital Tao Peng ( [email protected] ) the rst aliated hospital of guangxi medical university Research article Keywords: GPC family genes, pancreatic ductal adenocarcinoma, prognostic indicator, mechanism Posted Date: December 9th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-48421/v3 Page 1/32 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published on December 10th, 2020. See the published version at https://doi.org/10.1186/s12876-020-01560-0. Page 2/32 Abstract Background: This study explored the prognostic signicance of Glypican (GPC) family genes in patients with pancreatic ductal adenocarcinoma (PDAC) after pancreaticoduodenectomy using data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). -
Agonists Regulate the Expression of Stemness and Differentiation Genes in Brain Tumour Stem Cells
British Journal of Cancer (2012) 106, 1702–1712 & 2012 Cancer Research UK All rights reserved 0007 – 0920/12 www.bjcancer.com PPARg agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells E Pestereva1, S Kanakasabai1 and JJ Bright*,1,2 1 Neuroscience Research Laboratory, Methodist Research Institute, Indiana University Health, 1800 North Capitol Avenue, Noyes Building E504C, 2 Indianapolis, IN 46202, USA; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA BACKGROUND: Brain tumour stem cells (BTSCs) are a small population of cancer cells that exhibit self-renewal, multi-drug resistance, and recurrence properties. We have shown earlier that peroxisome proliferator-activated receptor gamma (PPARg) agonists inhibit the expansion of BTSCs in T98G and U87MG glioma. In this study, we analysed the influence of PPARg agonists on the expression of stemness and differentiation genes in BTSCs. METHODS: The BTSCs were isolated from T98G and DB29 glioma cells, and cultured in neurobasal medium with epidermal growth factor þ basic fibroblast growth factor. Proliferation was measured by WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2 H-5- tetrazolio]-1,3-benzene disulphonate) and 3H thymidine uptake assays, and gene expression was analysed by quantitative reverse– transcription PCR and Taqman array. The expression of CD133, SRY box 2, and nanog homeobox (Nanog) was also evaluated by western blotting, immunostaining, and flow cytometry. 12,14 RESULTS: We found that PPARg agonists, ciglitazone and 15-deoxy-D -ProstaglandinJ2, inhibited cell viability and proliferation of þ T98G- and DB29-BTSCs. The PPARg agonists reduced the expansion of CD133 BTSCs and altered the expression of stemness and differentiation genes. -
Glypicans Shield the Wnt Lipid Moiety to Enable Signalling at a Distance
Article Glypicans shield the Wnt lipid moiety to enable signalling at a distance https://doi.org/10.1038/s41586-020-2498-z Ian J. McGough1,3, Luca Vecchia2,3, Benjamin Bishop2, Tomas Malinauskas2, Karen Beckett1, Dhira Joshi1, Nicola O’Reilly1, Christian Siebold2, E. Yvonne Jones2,4 ✉ & Jean-Paul Vincent1 ✉ Received: 8 August 2019 Accepted: 23 April 2020 A relatively small number of proteins have been suggested to act as morphogens— Published online: 22 July 2020 signalling molecules that spread within tissues to organize tissue repair and the Check for updates specifcation of cell fate during development. Among them are Wnt proteins, which carry a palmitoleate moiety that is essential for signalling activity1–3. How a hydrophobic lipoprotein can spread in the aqueous extracellular space is unknown. Several mechanisms, such as those involving lipoprotein particles, exosomes or a specifc chaperone, have been proposed to overcome this so-called Wnt solubility problem4–6. Here we provide evidence against these models and show that the Wnt lipid is shielded by the core domain of a subclass of glypicans defned by the Dally-like protein (Dlp). Structural analysis shows that, in the presence of palmitoleoylated peptides, these glypicans change conformation to create a hydrophobic space. Thus, glypicans of the Dlp family protect the lipid of Wnt proteins from the aqueous environment and serve as a reservoir from which Wnt proteins can be handed over to signalling receptors. Wnt proteins are lipidated1, with a palmitoleate2 appended to a con- glycophosphatidylinositol (GPI) membrane anchor (DlpΔGPI) was used served serine residue (Ser209 in human WNT3A). Crystal structures as a positive control (Extended Data Fig. -
Pollination-Induced Gene Changes That Lead to Senescence in Petunia × Hybrida
Pollination-Induced Gene Changes That Lead to Senescence in Petunia × hybrida DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Shaun Robert Broderick, M.S. Graduate Program in Horticulture and Crop Science The Ohio State University 2014 Dissertation Committee: Michelle L. Jones, Advisor Feng Qu Eric J. Stockinger Esther van der Knaap Copyrighted by Shaun Robert Broderick 2014 Abstract Flower longevity is a genetically programmed event that ends in flower senescence. Flowers can last from several hours to several months, based on flower type and environmental factors. For many flowers, particularly those that are ethylene- sensitive, longevity is greatly reduced after pollination. Cellular components are disassembled and nutrients are remobilized during senescence, which reduces the net energy expenditures of floral structures. The goal of this research is to identify the genes that can be targeted to extent shelf life by inhibiting pollination-induced senescence. Identifying and characterizing regulatory shelf-life genes will enable breeders to incorporate specific alleles that improve post production quality into ethylene-sensitive crops. Petunia × hybrida is particularly amenable to flower longevity studies because of its large floral organs, predictable flower senescence timing, and importance in the greenhouse industry. A general approach to gene functional analysis involves reducing gene expression and observing the resulting phenotype. Viruses, such as tobacco rattle virus (TRV), can be used to induce gene silencing in plants like petunia. We optimized several parameters that improved virus-induced gene silencing (VIGS) in petunia by increasing the consistency and efficiency of silencing.